DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Frick MH, Elo O, Haapa K et al.
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
New Engl J Med 1987;
317: 1237-1245
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.